针对农村乳腺癌幸存者的在线表达性写作干预措施的可行性和可接受性:随机对照试验
Lilian J Shin-Cho1, Eunju Choi2, Lenna Dawkins-Moultin2
1Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
概括
在线表达式写作 (EW) 干预对于农村乳腺癌幸存者 (BCS) 是可行的和可以接受的. 试点研究显示生活质量 (QOL) 和疲劳的改善,表明EW可能有利于农村BCS.
科学领域:
- 在瘤学瘤学.
- 心理社会瘤学
- 数字健康干预措施 数字健康干预措施
背景情况:
- 农村乳腺癌幸存者 (BCS) 经历了独特的心理社会挑战,影响了生活质量 (QOL).
- 表达式写作 (EW) 是一种潜在的干预措施,但其在农村人口中的使用尚未得到充分研究.
研究的目的:
- 探索在线EW干预对农村BCS的可行性和可接受性.
- 评估QOL和疲劳的初步影响.
主要方法:
- 一项试点研究涉及34个农村BCS随机分配到EW干预或控制组.
- 干预包括阅读积极的信息,并在一个月内每周写一篇关于癌症经历的文章.
- 在基线和随访时评估了可行性,可接受性,质量生活和疲劳.
主要成果:
- 取得了令人满意的响应,遵守和完成率.
- 参与者普遍喜欢这项研究.
- 与对照组相比,EW组在QOL (d=0.51) 和疲劳 (d=-0.64) 中显示了中等效果大小的改善.
结论:
- 对于农村BCS来说,在线EW干预是可行的和可以接受的.
- 初步结果表明,对QOL和疲劳有潜在的益处.
- 需要进行更大规模的试验来确认在农村癌症幸存者群体中的疗效.
相关概念视频
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


